Industry News
Early study shows that two targeted drugs with chemotherapy is safe and effective in advanced NSCLC
Nov 05, 2013
A phase II study is the first to show that adding two targeted therapy drugs to the standard chemotherapy regimen is safe and effective as first-line treatment of advanced non-small-cell lung cancer (NSCLC). The researchers found that the safety of the drugs compared well with the safety reported in studies of the targeted drugs used alone with chemotherapy... Read More
Clinicians rate patients with lung cancer with poorer quality of life
Nov 05, 2013
Advances have been made in the treatment of lung cancer, but the disease continues to be a challenge to treat, primarily because of a high number of people who have late-stage cancer at the time of diagnosis, the likelihood of poor outcomes, and a greater symptom burden... Read More
We must regulate e-cigarettes and electronic nicotine delivery systems says International Union Against Tuberculosis and Lung Disease
Nov 05, 2013
At the 44th Union World Conference on Lung Health in Paris, members of the International Union Against Tuberculosis and Lung Health (The Union) issued a warning about the potential health impact of e-cigarettes and electronic nicotine delivery systems (ENDS) and called for urgent regulation of these products... Read More
International trauma project set to reduce fatalities
Nov 05, 2013
Several of the world's most renowned trauma teams, including Queen Mary University of London in partnership with The Royal London Hospital, are embarking on an extensive five-year project to investigate abnormal bleeding in trauma patients. The project, which has just begun, will aim to develop international guidelines to treat abnormal bleeding (known as coagulopathy) in trauma patients... Read More
Liver tropism is key for B cell deletion immunotherapy
Nov 05, 2013
Antibodies against the B cell surface protein CD20 have been used successfully to treat B cell-mediated autoimmune diseases and lymphomas. Antibody binding receptors, called Fc receptors, on other immune cells bind anti-CD20 on coated B cells, which induces B cell deletion through a mechanism that is not clearly understood... Read More
Promising results from experimental drug for treating the most common form of lung cancer
Nov 05, 2013
An experimental cancer drug that has shown promise in the treatment of melanoma has also shown early potential as an effective treatment for patients with non-small cell lung cancer, the leading cause of cancer death among men and women worldwide. Dr... Read More
Efforts to address cervical cancer hindered by leadership void, not lack of money
Nov 05, 2013
A study by Indiana University public health researchers found that the opportunity for significant progress in addressing cervical cancer across the country is being squandered -- not because of a lack of money, but because of a void of leadership and organization at the state levels... Read More
Guidelines, treatment options and care pathways to help prevent osteoporosis and fractures in cancer patients
Nov 05, 2013
Cancer is a health burden of increasing importance which affects close to 13 million people globally. Bone is often affected in these patients, frequently because of bone metastases, or as a result of anti-cancer therapies which can contribute to bone loss and fragility... Read More
Combination therapy could treat common children's cancer
Nov 05, 2013
A dual-pronged strategy using two experimental cancer drugs together could successfully treat a childhood cancer by inhibiting tumour growth and blocking off the escape routes it uses to become resistant to treatment, finds a new study... Read More
Genetic profiling identifies heart attack patients resistant to blood thinners
Nov 05, 2013
Results of the GIANT trial reported at TCT 2013 According to a new study, genetic profiling of patients undergoing percutaneous coronary intervention (PCI) may help cardiology teams adjust treatment and improve ischemic outcomes for patients that do not properly metabolize thienopyridine blood thinning therapies such as clopidogrel... Read More
Previous Page Next Page